Global Anti-Obesity Prescription Drugs Market Research Report 2021

Global Anti-Obesity Prescription Drugs Market Research Report 2021

Table of Contents
1 Anti-Obesity Prescription Drugs Market Overview
1.1 Product Overview and Scope of Anti-Obesity Prescription Drugs
1.2 Anti-Obesity Prescription Drugs Segment by Type
1.2.1 Global Anti-Obesity Prescription Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Pediatric
1.2.3 Adult
1.3 Anti-Obesity Prescription Drugs Segment by Application
1.3.1 Anti-Obesity Prescription Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.4 Global Anti-Obesity Prescription Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Obesity Prescription Drugs Revenue 2016-2027
1.4.2 Global Anti-Obesity Prescription Drugs Sales 2016-2027
1.4.3 Anti-Obesity Prescription Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Anti-Obesity Prescription Drugs Market Competition by Manufacturers
2.1 Global Anti-Obesity Prescription Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-Obesity Prescription Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-Obesity Prescription Drugs Manufacturing Sites, Area Served, Product Type
2.5 Anti-Obesity Prescription Drugs Market Competitive Situation and Trends
2.5.1 Anti-Obesity Prescription Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-Obesity Prescription Drugs Players Market Share by Revenue
2.5.3 Global Anti-Obesity Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Obesity Prescription Drugs Retrospective Market Scenario by Region
3.1 Global Anti-Obesity Prescription Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anti-Obesity Prescription Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anti-Obesity Prescription Drugs Market Facts & Figures by Country
3.3.1 North America Anti-Obesity Prescription Drugs Sales by Country
3.3.2 North America Anti-Obesity Prescription Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Obesity Prescription Drugs Market Facts & Figures by Country
3.4.1 Europe Anti-Obesity Prescription Drugs Sales by Country
3.4.2 Europe Anti-Obesity Prescription Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Obesity Prescription Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Obesity Prescription Drugs Sales by Region
3.5.2 Asia Pacific Anti-Obesity Prescription Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Obesity Prescription Drugs Market Facts & Figures by Country
3.6.1 Latin America Anti-Obesity Prescription Drugs Sales by Country
3.6.2 Latin America Anti-Obesity Prescription Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-Obesity Prescription Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales by Country
3.7.2 Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-Obesity Prescription Drugs Historic Market Analysis by Type
4.1 Global Anti-Obesity Prescription Drugs Sales Market Share by Type (2016-2021)
4.2 Global Anti-Obesity Prescription Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Anti-Obesity Prescription Drugs Price by Type (2016-2021)
5 Global Anti-Obesity Prescription Drugs Historic Market Analysis by Application
5.1 Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2016-2021)
5.2 Global Anti-Obesity Prescription Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Anti-Obesity Prescription Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 F Hoffmann La Roche Ltd
6.1.1 F Hoffmann La Roche Ltd Corporation Information
6.1.2 F Hoffmann La Roche Ltd Description and Business Overview
6.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 F Hoffmann La Roche Ltd Product Portfolio
6.1.5 F Hoffmann La Roche Ltd Recent Developments/Updates
6.2 Orexigen Therapeutics
6.2.1 Orexigen Therapeutics Corporation Information
6.2.2 Orexigen Therapeutics Description and Business Overview
6.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Orexigen Therapeutics Product Portfolio
6.2.5 Orexigen Therapeutics Recent Developments/Updates
6.3 Novo Nordisk A/s
6.3.1 Novo Nordisk A/s Corporation Information
6.3.2 Novo Nordisk A/s Description and Business Overview
6.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novo Nordisk A/s Product Portfolio
6.3.5 Novo Nordisk A/s Recent Developments/Updates
6.4 Arena Pharmaceuticals
6.4.1 Arena Pharmaceuticals Corporation Information
6.4.2 Arena Pharmaceuticals Description and Business Overview
6.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Arena Pharmaceuticals Product Portfolio
6.4.5 Arena Pharmaceuticals Recent Developments/Updates
6.5 Glaxosmithkline
6.5.1 Glaxosmithkline Corporation Information
6.5.2 Glaxosmithkline Description and Business Overview
6.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Glaxosmithkline Product Portfolio
6.5.5 Glaxosmithkline Recent Developments/Updates
6.6 Vivus
6.6.1 Vivus Corporation Information
6.6.2 Vivus Description and Business Overview
6.6.3 Vivus Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Vivus Product Portfolio
6.6.5 Vivus Recent Developments/Updates
6.7 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Boehringer Ingelheim Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Alizyme
6.8.1 Alizyme Corporation Information
6.8.2 Alizyme Description and Business Overview
6.8.3 Alizyme Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Alizyme Product Portfolio
6.8.5 Alizyme Recent Developments/Updates
7 Anti-Obesity Prescription Drugs Manufacturing Cost Analysis
7.1 Anti-Obesity Prescription Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Obesity Prescription Drugs
7.4 Anti-Obesity Prescription Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Obesity Prescription Drugs Distributors List
8.3 Anti-Obesity Prescription Drugs Customers
9 Anti-Obesity Prescription Drugs Market Dynamics
9.1 Anti-Obesity Prescription Drugs Industry Trends
9.2 Anti-Obesity Prescription Drugs Growth Drivers
9.3 Anti-Obesity Prescription Drugs Market Challenges
9.4 Anti-Obesity Prescription Drugs Market Restraints
10 Global Market Forecast
10.1 Anti-Obesity Prescription Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Obesity Prescription Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-Obesity Prescription Drugs by Type (2022-2027)
10.2 Anti-Obesity Prescription Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Obesity Prescription Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-Obesity Prescription Drugs by Application (2022-2027)
10.3 Anti-Obesity Prescription Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Obesity Prescription Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-Obesity Prescription Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Anti-Obesity Prescription Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anti-Obesity Prescription Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Anti-Obesity Prescription Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anti-Obesity Prescription Drugs Covered in This Study
Table 5. Global Anti-Obesity Prescription Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Anti-Obesity Prescription Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Anti-Obesity Prescription Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anti-Obesity Prescription Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anti-Obesity Prescription Drugs Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anti-Obesity Prescription Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-Obesity Prescription Drugs Product Type
Table 12. Global Anti-Obesity Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Obesity Prescription Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Obesity Prescription Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-Obesity Prescription Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Anti-Obesity Prescription Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Anti-Obesity Prescription Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anti-Obesity Prescription Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Anti-Obesity Prescription Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Anti-Obesity Prescription Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anti-Obesity Prescription Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Anti-Obesity Prescription Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Anti-Obesity Prescription Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Anti-Obesity Prescription Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anti-Obesity Prescription Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anti-Obesity Prescription Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Anti-Obesity Prescription Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anti-Obesity Prescription Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anti-Obesity Prescription Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anti-Obesity Prescription Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Anti-Obesity Prescription Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Anti-Obesity Prescription Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anti-Obesity Prescription Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anti-Obesity Prescription Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Anti-Obesity Prescription Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anti-Obesity Prescription Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Anti-Obesity Prescription Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Anti-Obesity Prescription Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Anti-Obesity Prescription Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anti-Obesity Prescription Drugs Revenue Share by Type (2016-2021)
Table 42. Global Anti-Obesity Prescription Drugs Price (US$/Unit) by Type (2016-2021)
Table 43. Global Anti-Obesity Prescription Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Anti-Obesity Prescription Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anti-Obesity Prescription Drugs Revenue Share by Application (2016-2021)
Table 47. Global Anti-Obesity Prescription Drugs Price (US$/Unit) by Application (2016-2021)
Table 48. F Hoffmann La Roche Ltd Corporation Information
Table 49. F Hoffmann La Roche Ltd Description and Business Overview
Table 50. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product
Table 52. F Hoffmann La Roche Ltd Recent Developments/Updates
Table 53. Orexigen Therapeutics Corporation Information
Table 54. Orexigen Therapeutics Description and Business Overview
Table 55. Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Orexigen Therapeutics Anti-Obesity Prescription Drugs Product
Table 57. Orexigen Therapeutics Recent Developments/Updates
Table 58. Novo Nordisk A/s Corporation Information
Table 59. Novo Nordisk A/s Description and Business Overview
Table 60. Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Novo Nordisk A/s Anti-Obesity Prescription Drugs Product
Table 62. Novo Nordisk A/s Recent Developments/Updates
Table 63. Arena Pharmaceuticals Corporation Information
Table 64. Arena Pharmaceuticals Description and Business Overview
Table 65. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product
Table 67. Arena Pharmaceuticals Recent Developments/Updates
Table 68. Glaxosmithkline Corporation Information
Table 69. Glaxosmithkline Description and Business Overview
Table 70. Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Glaxosmithkline Anti-Obesity Prescription Drugs Product
Table 72. Glaxosmithkline Recent Developments/Updates
Table 73. Vivus Corporation Information
Table 74. Vivus Description and Business Overview
Table 75. Vivus Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Vivus Anti-Obesity Prescription Drugs Product
Table 77. Vivus Recent Developments/Updates
Table 78. Boehringer Ingelheim Corporation Information
Table 79. Boehringer Ingelheim Description and Business Overview
Table 80. Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Boehringer Ingelheim Anti-Obesity Prescription Drugs Product
Table 82. Boehringer Ingelheim Recent Developments/Updates
Table 83. Alizyme Corporation Information
Table 84. Alizyme Description and Business Overview
Table 85. Alizyme Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Alizyme Anti-Obesity Prescription Drugs Product
Table 87. Alizyme Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Anti-Obesity Prescription Drugs Distributors List
Table 91. Anti-Obesity Prescription Drugs Customers List
Table 92. Anti-Obesity Prescription Drugs Market Trends
Table 93. Anti-Obesity Prescription Drugs Growth Drivers
Table 94. Anti-Obesity Prescription Drugs Market Restraints
Table 95. Global Anti-Obesity Prescription Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Anti-Obesity Prescription Drugs Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Anti-Obesity Prescription Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Anti-Obesity Prescription Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Anti-Obesity Prescription Drugs Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Anti-Obesity Prescription Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Anti-Obesity Prescription Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Anti-Obesity Prescription Drugs Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Anti-Obesity Prescription Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Obesity Prescription Drugs
Figure 2. Global Anti-Obesity Prescription Drugs Market Share by Type in 2020 & 2027
Figure 3. Pediatric Product Picture
Figure 4. Adult Product Picture
Figure 5. Global Anti-Obesity Prescription Drugs Market Share by Application in 2020 & 2027
Figure 6. Hospitals Pharmacies
Figure 7. Retail Pharmacies
Figure 8. E-commerce
Figure 9. Global Anti-Obesity Prescription Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anti-Obesity Prescription Drugs Market Size 2016-2027 (US$ Million)
Figure 11. Global Anti-Obesity Prescription Drugs Sales 2016-2027 (K Units)
Figure 12. Global Anti-Obesity Prescription Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Anti-Obesity Prescription Drugs Sales Share by Manufacturers in 2020
Figure 14. Global Anti-Obesity Prescription Drugs Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Anti-Obesity Prescription Drugs Players: Market Share by Revenue in 2020
Figure 16. Anti-Obesity Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Anti-Obesity Prescription Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Anti-Obesity Prescription Drugs Sales Market Share by Region in 2020
Figure 19. Global Anti-Obesity Prescription Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global Anti-Obesity Prescription Drugs Revenue Market Share by Region in 2020
Figure 21. U.S. Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Anti-Obesity Prescription Drugs by Type (2016-2021)
Figure 46. Sales Market Share of Anti-Obesity Prescription Drugs by Application (2016-2021)
Figure 47. Sales Market Share of Anti-Obesity Prescription Drugs by Application in 2020
Figure 48. Revenue Share of Anti-Obesity Prescription Drugs by Application (2016-2021)
Figure 49. Revenue Share of Anti-Obesity Prescription Drugs by Application in 2020
Figure 50. Manufacturing Cost Structure of Anti-Obesity Prescription Drugs
Figure 51. Manufacturing Process Analysis of Anti-Obesity Prescription Drugs
Figure 52. Anti-Obesity Prescription Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs